“…The next few submissions largely relate to bleeding disorders and their management. First, Chandran and colleagues discuss aspects of the management of hemophilia A, 6 which has undergone a remarkable revolution, in line with technological advancement, in recent years. Once, the primary concern associated with Factor VIII (FVIII) concentrates was the risk of infections, which is now almost resolved by advanced blood screening and viral inactivation methods.…”